SCHEMBL6996945

SCHEMBL6996945

[CH2]C(N)Oc1ccc(-c2coc(C)n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 6/20 0.60
ENPP1 P22413 4/20 0.54
TP53 P04637 5/20 0.48
POLB P06746 3/20 0.43
THRB P10828 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
LTA4H P09960 1/20 0.39
MAPT P10636 1/20 0.39
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL201523 0.77 ENPP3 (0.96) ENPP3ENPP1TP53POLBTHRB
SCHEMBL7148308 0.76 AOC3 (0.48) ENPP3ENPP1
SCHEMBL8117354 0.73 ENPP3 (0.69) ENPP3ENPP1TP53POLBTHRB
SCHEMBL19626581 0.73 ENPP3 (0.66) ENPP3ENPP1TP53POLBTHRB
SCHEMBL6326200 0.73 ENPP3 (0.60) ENPP3ENPP1TP53POLBTHRB
SCHEMBL12112408 0.73 ENPP3 (0.96) ENPP3ENPP1TP53POLBTHRB
SCHEMBL2056108 0.72 TP53 (0.69) ENPP3ENPP1TP53POLBTHRB
Ammonia Solution, Strong SCHEMBL28862464 0.71 ENPP3 (0.92) ENPP3ENPP1TP53POLBTHRB
SCHEMBL24415640 0.70 ENPP3 (0.69) ENPP3ENPP1TP53POLBTHRB
SCHEMBL2056109 0.70 ENPP3 (0.69) ENPP3ENPP1TP53POLBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326861-A1 ALPHA-ARYL ETHANOLAMINES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS Pfizer Products Inc. (US) 2003-07-16 EP disclosed
WO-2002032897-A1 ALPHA-ARYL ETHANOLAMINES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS PFIZER PRODUCTS INC. (US) 2002-04-25 WO disclosed